Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EBIT (2021 - 2025)

Biote has reported EBIT over the past 5 years, most recently at $27.5 million for Q4 2025.

  • Quarterly results put EBIT at $27.5 million for Q4 2025, up 196.07% from a year ago — trailing twelve months through Dec 2025 was $56.2 million (up 26297.65% YoY), and the annual figure for FY2025 was $120.8 million, up 56608.45%.
  • EBIT for Q4 2025 was $27.5 million at Biote, up from $8.3 million in the prior quarter.
  • Over the last five years, EBIT for BTMD hit a ceiling of $27.5 million in Q4 2025 and a floor of -$85.6 million in Q2 2022.
  • Median EBIT over the past 5 years was $7.8 million (2022), compared with a mean of $1.0 million.
  • Peak annual rise in EBIT hit 9150.29% in 2022, while the deepest fall reached 934.34% in 2022.
  • Biote's EBIT stood at $5.9 million in 2021, then increased by 23.26% to $7.3 million in 2022, then tumbled by 417.73% to -$23.2 million in 2023, then decreased by 23.39% to -$28.6 million in 2024, then surged by 196.07% to $27.5 million in 2025.
  • The last three reported values for EBIT were $27.5 million (Q4 2025), $8.3 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.